Capricor Therapeutics

Nachrichten

Capricor Therapeutics Aktie

Aktie

ISIN: US14070B3096 WKN: A2PLU4 SYM: CAPR Land Flagge US

USA

Zur Watchlist hinzufügen Zum Portfolio hinzufügen

Zum Portfolio hinzufügen

8,5600

USD

-2,84 %

-0,2500 USD

Letzter Kurs 02:00:00 Nasdaq

Capricor Therapeutics Aktie kaufen

Geldkurs

15.09.26

8,5600

USD

15.500 STK

Briefkurs

15.09.26

8,5800

USD

1.000 STK

Verkauf

Kauf

Hinweis
Verlängerte Handelszeiten
Mo-Fr von 07:30 bis 23:00 Uhr
Neu: Samstag von 14:00 bis 19:00 Uhr

Nachrichten zu Capricor Therapeutics

Neueste Meldungen

Kaplan Fox Urges Investors of Capricor Therapeutics, Inc. (CAPR) to Contact the Firm Before the Securities Class Action Deadline on September 28, 2026 Englische Nachricht

Kaplan Fox Advises Investors of Capricor Therapeutics, Inc. (CAPR) to Contact the Firm Before the Deadline on September 28, 2026 Englische Nachricht

Artikel in Nachrichten zu Capricor Therapeutics

Neueste
Meistgelesene

CAPR INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds Capricor Investors of Securities Class Action Lawsuit Deadline on September 28, 2026 13.09.26 · newsfile
Kaplan Fox Encourages Capricor Therapeutics, Inc. (CAPR) Investors Who Suffered Losses to Seek a Leadership Role Before September 28, 2026 11.09.26 · newsfile
CAPR INVESTOR DEADLINE: Capricor Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Shareholder Class Action Lawsuit Before September 28, 2026 Deadline 11.09.26 · newsfile
SHAREHOLDER REMINDER: Berger Montague Reminds Capricor Therapeutics, Inc. (CAPR) Investors of the September 28, 2026 Deadline 11.09.26 · newsfile
Kaplan Fox Reminds Capricor Therapeutics, Inc. (CAPR) Investors of an Approaching Securities Class Action Deadline on September 28, 2026 10.09.26 · newsfile
CAPR EQUITY ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Capricor Investors of Securities Class Action Lawsuit Deadline on September 28, 2026 10.09.26 · newsfile
Kaplan Fox Alerts Investors of Capricor Therapeutics, Inc. (CAPR) to an Upcoming Deadline of September 28, 2026 in the Securities Class Action 09.09.26 · newsfile
CLASS ACTION DEADLINE APPROACHING: Berger Montague Advises Capricor Therapeutics, Inc. (CAPR) Investors to Inquire About a Securities Fraud Class Action by September 28, 2026 09.09.26 · newsfile
LAWSUIT INVESTOR NOTICE: Investors who lost money with Capricor Therapeutics, Inc. (NASDAQ: CAPR) shares should contact the Shareholders Foundation 09.09.26 · Business Wire (engl.)
CAPR INVESTOR DEADLINE: Capricor Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Shareholder Class Action Lawsuit Before September 28, 2026 Deadline 09.09.26 · newsfile
Kaplan Fox Notifies Capricor Therapeutics, Inc. (CAPR) Investors of a Securities Class Action Lawsuit - Deadline is September 28, 2026 08.09.26 · newsfile
CAPR DEADLINE ALERT: ROSEN, A TOP RANKED LAW FIRM, Encourages Capricor Therapeutics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - CAPR 08.09.26 · newsfile
CAPR SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Capricor Investors of Securities Class Action Lawsuit Deadline on September 28, 2026 07.09.26 · newsfile
CAPR IMPORTANT DEADLINE: ROSEN, LEADING TRIAL ATTORNEYS, Encourages Capricor Therapeutics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - CAPR 07.09.26 · newsfile
CAPR DEADLINE NOTICE: ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Capricor Therapeutics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - CAPR 06.09.26 · newsfile
CAPR CLASS ACTION NOTICE: Faruqi & Faruqi, LLP Reminds Capricor Investors of Securities Class Action Lawsuit Deadline on September 28, 2026 05.09.26 · newsfile
CAPR DEADLINE ALERT: ROSEN, A TOP RANKED LAW FIRM, Encourages Capricor Therapeutics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - CAPR 05.09.26 · newsfile
Kaplan Fox Encourages Investors of Capricor Therapeutics, Inc. (CAPR) to Act Ahead of the Lead Plaintiff Deadline on September 28, 2026 04.09.26 · newsfile
CAPR INVESTOR DEADLINE: Capricor Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Shareholder Class Action Lawsuit Before September 28 Deadline 04.09.26 · newsfile
CAPR DEADLINE NOTICE: ROSEN, LEADING INVESTOR COUNSEL, Encourages Capricor Therapeutics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - CAPR 04.09.26 · newsfile
Kaplan Fox Reminds Investors of a Deadline for a Securities Fraud Class Action Lawsuit Against Capricor Therapeutics, Inc. (CAPR) on September 28, 2026 03.09.26 · newsfile
CAPR DEADLINE: ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Capricor Therapeutics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - CAPR 03.09.26 · newsfile
Capricor Therapeutics, Inc. Notice of September 28, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline 03.09.26 · newsfile
CAPR INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds Capricor Investors of Securities Class Action Lawsuit Deadline on September 28, 2026 02.09.26 · newsfile
CAPR Stock Drop: Robbins LLP Reminds Investors They May Be Eligible to Lead the Class Action Against Capricor Therapeutics, Inc. 02.09.26 · newsfile

1
2
3
…
4

24h
7 Tage
30 Tage
6 Monate

Kaplan Fox Urges Investors of Capricor Therapeutics, Inc. (CAPR) to Contact the Firm Before the Securities Class Action Deadline on September 28, 2026 15.09.26 · newsfile · 108 Leser

CAPR INVESTOR DEADLINE: Capricor Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Shareholder Class Action Lawsuit Before September 28, 2026 Deadline 09.09.26 · newsfile · 148 Leser
Kaplan Fox Alerts Investors of Capricor Therapeutics, Inc. (CAPR) to an Upcoming Deadline of September 28, 2026 in the Securities Class Action 09.09.26 · newsfile · 144 Leser
Kaplan Fox Encourages Capricor Therapeutics, Inc. (CAPR) Investors Who Suffered Losses to Seek a Leadership Role Before September 28, 2026 11.09.26 · newsfile · 144 Leser
CAPR EQUITY ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Capricor Investors of Securities Class Action Lawsuit Deadline on September 28, 2026 10.09.26 · newsfile · 136 Leser
CAPR INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds Capricor Investors of Securities Class Action Lawsuit Deadline on September 28, 2026 13.09.26 · newsfile · 136 Leser
CLASS ACTION DEADLINE APPROACHING: Berger Montague Advises Capricor Therapeutics, Inc. (CAPR) Investors to Inquire About a Securities Fraud Class Action by September 28, 2026 09.09.26 · newsfile · 132 Leser
CAPR INVESTOR DEADLINE: Capricor Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Shareholder Class Action Lawsuit Before September 28, 2026 Deadline 11.09.26 · newsfile · 132 Leser
SHAREHOLDER REMINDER: Berger Montague Reminds Capricor Therapeutics, Inc. (CAPR) Investors of the September 28, 2026 Deadline 11.09.26 · newsfile · 128 Leser
LAWSUIT INVESTOR NOTICE: Investors who lost money with Capricor Therapeutics, Inc. (NASDAQ: CAPR) shares should contact the Shareholders Foundation 09.09.26 · Business Wire (engl.) · 120 Leser
Kaplan Fox Reminds Capricor Therapeutics, Inc. (CAPR) Investors of an Approaching Securities Class Action Deadline on September 28, 2026 10.09.26 · newsfile · 116 Leser

70 Prozent Kurssprung nach FDA-Signal: Warum Zelltherapie-Aktien plötzlich wieder Anleger elektrisieren 26.08.26 · Small- & MicroCap Investment · 732 LeserAnzeige
Faruqi & Faruqi, LLP Urges Capricor Therapeutics, Inc. (CAPR) Investors to Seek Counsel Before the September 28, 2026 Lead Plaintiff Deadline in the Securities Class Action 26.08.26 · newsfile · 308 Leser
Kaplan Fox Notifies Investors of Capricor Therapeutics, Inc. (CAPR) of a Securities Fraud Class Action Deadline on September 28, 2026 21.08.26 · newsfile · 256 Leser
ATTENTION CAPR INVESTORS: Contact Berger Montague About a Capricor Therapeutics, Inc. Class Action Lawsuit 17.08.26 · newsfile · 240 Leser
ROSEN, NATIONAL TRIAL LAWYERS, Encourages Capricor Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CAPR 17.08.26 · newsfile · 240 Leser
ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Capricor Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CAPR 20.08.26 · newsfile · 228 Leser
Kaplan Fox Encourages Capricor Therapeutics, Inc. (CAPR) Investors to Contact the Firm Before the Lead Plaintiff Deadline on September 28, 2026 20.08.26 · newsfile · 224 Leser
Robbins LLP Urges CAPR Stockholders to Contact the Firm for Information About the Class Action Against Capricor Therapeutics, Inc. 19.08.26 · Business Wire (engl.) · 220 Leser
Capricor Therapeutics, Inc. (CAPR) Securities Fraud: Contact Berger Montague To Discuss Your Rights 28.08.26 · newsfile · 216 Leser
ROSEN, A NATIONALLY RECOGNIZED LAW FIRM, Encourages Capricor Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CAPR 28.08.26 · newsfile · 212 Leser

DAX, Capricor Therapeutics & Co. – Tops & Flops der Community am Nachmittag 14.08.26 · Markt Bote · 1008 Leser
DAX, LiveWire Group & Co. – Tops & Flops der Community am Nachmittag 27.07.26 · Markt Bote · 808 Leser
70 Prozent Kurssprung nach FDA-Signal: Warum Zelltherapie-Aktien plötzlich wieder Anleger elektrisieren 26.08.26 · Small- & MicroCap Investment · 732 LeserAnzeige
Fokus Aktien mit extremen Handelsvolumen am Freitag, den 14.08.2026 14.08.26 · wO Chartvergleich · 516 Leser
CAPR INVESTIGATION: Capricor Therapeutics Investors Should Contact Block & Leviton About Recovering Their Losses 29.07.26 · newsfile · 512 Leser
Capricor Therapeutics Announces FDA Advisory Committee Meeting to Review BLA for Deramiocel for the Treatment of Duchenne Muscular Dystrophy 26.06.26 · globenewswire · 384 Leser
Shareholder Alert - Robbins LLP Informs Investors of the Capricor Therapeutics, Inc. Class Action Lawsuit 01.08.26 · Business Wire (engl.) · 360 Leser
INVESTOR ALERT: Capricor Therapeutics, Inc. (CAPR) Investors with Substantial Losses Have Opportunity to Lead the Capricor Class Action Lawsuit 07.08.26 · newsfile · 356 Leser
ROSEN, REGARDED INVESTOR COUNSEL, Encourages Capricor Therapeutics Inc. Investors to Inquire About Securities Class Action Investigation - CAPR 01.08.26 · newsfile · 348 Leser
CAPR Investors Have Opportunity to Lead Capricor Therapeutics, Inc. Securities Fraud Lawsuit with SBS Law 01.08.26 · Business Wire (engl.) · 308 Leser

Capricor Therapeutics News

Capricor Therapeutics News: Auf dieser Seite finden Sie alle Capricor Therapeutics News und Nachrichten zur Capricor Therapeutics Aktie. Dies beinhaltet die Agenturmeldungen auf wallstreet-online.de, aber auch Capricor Therapeutics News von einer Vielzahl an Gastautoren, Partnern und Analysten.